We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+5.67%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$198B
AUM Growth
+$712M
Cap. Flow
-$13.1B
Cap. Flow %
-6.63%
Top 10 Hldgs %
21.74%
Holding
10,995
New
1,488
Increased
3,477
Reduced
3,725
Closed
2,170

Sector Composition

Rank Sector Weight
1 Healthcare 1.22%
2 Technology 1.15%
3 Consumer Discretionary 1.1%
4 Financials 1.05%
5 Communication Services 0.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAHC icon
9651
Phibro Animal Health
PAHC
$1.48B
-26,922
Closed -$789K
PAYX icon
9652
Paychex
PAYX
$44.5B
-52,700
Closed -$3.2M
PB icon
9653
Prosperity Bancshares
PB
$8.81B
-83,784
Closed -$6.08M
PBH icon
9654
Prestige Consumer Healthcare
PBH
$2.44B
-84,337
Closed -$4.65M
PBH icon
9655
PUT
Prestige Consumer Healthcare
PBH
$2.44B
-5,500
Closed -$287K
PBPB
9656
DELISTED
Potbelly
PBPB
-34,084
Closed -$448K
PCRX icon
9657
Pacira BioSciences
PCRX
$1.02B
-264,726
Closed -$11.4M
PCTY icon
9658
Paylocity
PCTY
$8.06B
-34,292
Closed -$1.19M
PCY icon
9659
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.3B
-34,615
Closed -$978K
PDSB icon
9660
PDS Biotechnology
PDSB
$12.3M
-1,312
Closed -$328K
PDT
9661
John Hancock Premium Dividend Fund
PDT
$622M
-14,916
Closed -$233K
PEBO icon
9662
Peoples Bancorp
PEBO
$1.43B
-25,098
Closed -$815K
PEGA icon
9663
Pegasystems
PEGA
$5.56B
-148,446
Closed -$3.01M
PEN icon
9664
Penumbra
PEN
$12.7B
-40,583
Closed -$3.07M
PENN icon
9665
PENN Entertainment
PENN
$2.33B
-135,328
Closed -$1.98M
PFF icon
9666
iShares Preferred and Income Securities ETF
PFF
$13.1B
-26,378
Closed -$1.01M
PFIS icon
9667
Peoples Financial Services
PFIS
$701M
-10,931
Closed -$532K
PFLT icon
9668
PennantPark Floating Rate Capital
PFLT
$740M
-52,538
Closed -$741K
PFS icon
9669
Provident Financial Services
PFS
$3.08B
-96,955
Closed -$2.74M
PFX icon
9670
CALL
PhenixFIN
PFX
$102M
-2,010
Closed -$302K
PFX icon
9671
PhenixFIN
PFX
$102M
-727
Closed -$109K
PFX icon
9672
PUT
PhenixFIN
PFX
$102M
-1,205
Closed -$181K
PG icon
9673
Procter & Gamble
PG
$337B
-1,593,922
Closed -$141M
PGC icon
9674
Peapack-Gladstone Financial
PGC
$805M
-26,164
Closed -$808K
PGF icon
9675
CALL
Invesco Financial Preferred ETF
PGF
$662M
-11,900
Closed -$214K

Similar funds

Jeff Yass's Q1 2017 Portfolio in Review

As of Q1 2017, Jeff Yass held 10,995 positions worth $198B, up 0.36% from $197B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Jeff Yass withdrew a net $13.1B in Q1 2017, closing 2,170 positions and reducing 3,725 holdings. Its most notable exit was Air Products & Chemicals, an estimated $219M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 1.2% of assets, down from 1.2% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Jeff Yass opened a new position in iShares MSCI EAFE ETF worth $131M.

  • Jeff Yass's largest Q1 2017 buy was iShares MSCI EAFE ETF: 2,100,985 shares worth $131M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2017, an estimated $879M increase.
  • Jeff Yass's biggest Q1 2017 reduction was Apple, cutting an estimated $1.82B.
  • Jeff Yass fully exited Air Products & Chemicals in Q1 2017, selling an estimated $219M.
  • Jeff Yass's ten largest holdings make up 22% of its $198B portfolio in Q1 2017.
  • Jeff Yass opened 1,488 new positions and closed 2,170 in Q1 2017.
  • Jeff Yass's portfolio value rose 0.36% quarter-over-quarter to $198B.

Based on Susquehanna International Group's 13F filing for Q1 2017, filed 15 May 2017.